Daniel Selchen

Atrial Fibrillation in Patients with Cryptogenic Stroke

David J. Gladstone, Melanie Spring, Paul Dorian et al. · New England Journal of Medicine · 2014 · 1.3K citations · Full text

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial

Michael D. Hill, Mayank Goyal, Bijoy K. Menon et al. · The Lancet · 2020 · 601 citations · Full text

Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial

Bruce Cree, Gary Cutter, Jerry S. Wolinsky et al. · The Lancet Neurology · 2020 · 99 citations · Full text

Posterior cortical dementia with alexia: neurobehavioural, MRI, and PET findings.

Lawrence R. Freedman, Daniel Selchen, Sandra E. Black et al. · Journal of Neurology Neurosurgery & Psychiatry · 1991 · 81 citations · Full text

Treatment experience, burden, and unmet needs (TRIBUNE) in multiple sclerosis: the costs and utilities of MS patients in Canada.

Korinna Karampampa, Anders Gustavsson, Carolin Miltenburger et al. · PubMed · 2012 · 72 citations